{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:27:05Z","timestamp":1784982425270,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.atherosclerosis.2013.09.031","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T02:40:12Z","timestamp":1381891212000},"page":"411-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects"],"prefix":"10.1016","volume":"231","author":[{"given":"Zohara","family":"Sternberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Chichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hojnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Munschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2967\/jnumed.107.038661","article-title":"Role of inflammation in atherosclerosis","volume":"48","author":"Spagnoli","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MOL.0b013e32832fa58d","article-title":"Circulating oxidized LDL: a biomarker and a pathogenic factor","volume":"20","author":"Ishigaki","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease","volume":"46","author":"Park","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib5","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1194\/jlr.P900004-JLR200","article-title":"Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and\/or simvastatin in men","volume":"50","author":"Sudhop","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1507\/endocrj.K10E-165","article-title":"Efficacy and safety of ezetimibe in patients undergoing hemodialysis","volume":"57","author":"Hattori","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2008.03.021","article-title":"Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice","volume":"202","author":"Kuhlencordt","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5551\/jat.2378","article-title":"Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia","volume":"17","author":"Yagi","year":"2010","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5551\/jat.10835","article-title":"Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia","volume":"19","author":"Tamaki","year":"2012","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FJC.0b013e318211703b","article-title":"The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia","volume":"57","author":"Krysiak","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.10.021","article-title":"Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients","volume":"179","author":"Sager","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0b013e3181bfb1a2","article-title":"Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin\/ezetimibe coadministration","volume":"55","author":"Araujo","year":"2010","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1074248413489771","article-title":"Increasing doses of simvastatin versus combined Ezetimibe\/Simvastatin: effect on circulating endothelial progenitor cells","author":"Pesaro","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib15","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1172\/JCI117213","article-title":"Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver","volume":"93","author":"Powell","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib16","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: a pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib19","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib20","doi-asserted-by":"crossref","first-page":"e12336","DOI":"10.1371\/journal.pone.0012336","article-title":"Should we abandon the t-test in the analysis of gene expression microarray data: a comparison of variance modeling strategies","volume":"5","author":"Jeanmougin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1538-7836.2005.01211.x","article-title":"Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in\u00a0vivo regulation of hemostasis, inflammation and apoptosis","volume":"3","author":"Wibaut-Berlaimont","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib22","first-page":"567","article-title":"The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation","volume":"3","author":"Gelosa","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib23","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1161\/01.CIR.0000164260.82417.3F","article-title":"Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans","volume":"111","author":"Landmesser","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1734-1140(10)70338-8","article-title":"Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB): a new potential therapeutic target in atherosclerosis?","volume":"62","author":"Dabek","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1083\/jcb.200609166","article-title":"Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway","volume":"177","author":"Cude","year":"2007","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jcp.20644","article-title":"The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-kappaB pathway","volume":"208","author":"Miranda","year":"2006","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib27","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1161\/CIRCRESAHA.108.188771","article-title":"Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes","volume":"104","author":"Collins","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.2011.18","article-title":"Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in\u00a0vitro and in\u00a0vivo","volume":"79","author":"Zhao","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib29","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/ATVBAHA.109.194738","article-title":"Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells","volume":"29","author":"Wagner","year":"2009","journal-title":"Arteriosc Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FJC.0b013e31821e8cb2","article-title":"Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events","volume":"58","author":"Undas","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib31","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1096\/fj.09-148155","article-title":"Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice","volume":"24","author":"Han","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib32","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.20100414","article-title":"IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages","volume":"207","author":"Smallie","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11883-001-0066-z","article-title":"Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis","volume":"3","author":"Geng","year":"2001","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0162-3109(00)00272-1","article-title":"Stimulation of inflammatory responses in\u00a0vitro and in\u00a0vivo by lipophilic HMG-CoA reductase inhibitors","volume":"1","author":"Kiener","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/CS20030148","article-title":"Statins and their role in vascular protection","volume":"105","author":"Mason","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cvr\/cvn157","article-title":"Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB\/iNOS","volume":"80","author":"Mikael","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2013.09.031_bib37","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","article-title":"Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease","volume":"11","author":"Austin","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2004.07.022","article-title":"Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women","volume":"177","author":"Szeplaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.lfs.2009.01.012","article-title":"TNFalpha- and NF-kappaB-dependent induction of the chemokine CCL1 in human macrophages exposed to the atherogenic lipoprotein(a)","volume":"84","author":"N'Diaye","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/heart.89.8.893","article-title":"Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia","volume":"89","author":"van Wissen","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib42","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurheartj\/ehi881","article-title":"Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy","volume":"27","author":"Fichtlscherer","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2011.01.062","article-title":"Pleiotropic effects of ezetimibe\/simvastatin vs. high dose simvastatin","volume":"158","author":"Pesaro","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.molimm.2005.06.045","article-title":"Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist","volume":"43","author":"Voleti","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib45","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib46","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2008.10.031","article-title":"Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial","volume":"52","author":"Fleg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1479164111406457","article-title":"Achievement of recommended lipid and lipoprotein levels with combined ezetimibe\/statin therapy versus statin alone in patients with and without diabetes","volume":"8","author":"Guyton","year":"2011","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1476-511X-10-146","article-title":"Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients","volume":"10","author":"Abramson","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.12799","article-title":"Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes","volume":"19","author":"Shigematsu","year":"2012","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/0091270009337011","article-title":"The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study","volume":"49","author":"Meaney","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2011.09.033","article-title":"Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in taiwan","volume":"33","author":"Katsiki","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib52","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1472-8206.2003.00233.x","article-title":"Rationale, design and methods of the CASHMERE study","volume":"18","author":"Simon","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib55","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/01.CIR.0000125700.33637.B1","article-title":"Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors","volume":"109","author":"Waehre","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib57","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1185\/030079908X273273","article-title":"The efficacy of statin monotherapy uptitration versus switching to ezetimibe\/simvastatin: results of the EASEGO study","volume":"24","author":"Roeters van Lennep","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jacl.2011.06.004","volume":"5","author":"Robinson","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib59","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ahj.2008.07.023","article-title":"Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes","volume":"156","author":"Cannon","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.09.031_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.exphem.2011.11.008","article-title":"Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients","volume":"40","author":"van der Weide","year":"2012","journal-title":"Exp Hematol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501300590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501300590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T01:10:27Z","timestamp":1596676227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501300590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S002191501300590X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.031","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}